Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Sanofi (SNY) Other Gross PP&E Adjustments (2016 - 2026)

Sanofi's Other Gross PP&E Adjustments history spans 18 years, with the latest figure at -$1.8 billion for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 10.14% to -$1.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.8 billion, a 10.14% decrease, with the full-year FY2025 number at -$1.7 billion, down 5.25% from a year prior.
  • Other Gross PP&E Adjustments hit -$1.8 billion in Q1 2026 for Sanofi, down from -$1.7 billion in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for SNY hit a ceiling of $567.3 million in Q4 2022 and a floor of -$2.0 billion in Q2 2022.
  • Historically, Other Gross PP&E Adjustments has averaged -$1.5 billion across 5 years, with a median of -$1.7 billion in 2025.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 283.23% in 2023 and later increased 7.25% in 2024.
  • Tracing SNY's Other Gross PP&E Adjustments over 5 years: stood at $567.3 million in 2022, then crashed by 283.23% to -$1.0 billion in 2023, then plummeted by 55.25% to -$1.6 billion in 2024, then fell by 5.25% to -$1.7 billion in 2025, then decreased by 4.57% to -$1.8 billion in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for SNY at -$1.8 billion in Q1 2026, -$1.7 billion in Q4 2025, and -$1.7 billion in Q3 2025.